Jeffrey N. Joyce

8.8k total citations
114 papers, 7.4k citations indexed

About

Jeffrey N. Joyce is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Jeffrey N. Joyce has authored 114 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Cellular and Molecular Neuroscience, 46 papers in Molecular Biology and 43 papers in Neurology. Recurrent topics in Jeffrey N. Joyce's work include Neurotransmitter Receptor Influence on Behavior (65 papers), Neuroscience and Neuropharmacology Research (46 papers) and Receptor Mechanisms and Signaling (36 papers). Jeffrey N. Joyce is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (65 papers), Neuroscience and Neuropharmacology Research (46 papers) and Receptor Mechanisms and Signaling (36 papers). Jeffrey N. Joyce collaborates with scholars based in United States, Japan and France. Jeffrey N. Joyce's co-authors include John F. Marshall, Carol Van Hartesveldt, Mark J. Millan, H. Ryoo, Eugenia V. Gurevich, Nedra Lexow, Andrew Winokur, Bethany S. Neal‐Beliveau, Sabine Borwege and Valeriy Duka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Jeffrey N. Joyce

114 papers receiving 7.3k citations

Peers

Jeffrey N. Joyce
Christine Konradi United States
William O. Whetsell United States
Karen Gale United States
Dwight C. German United States
John D. Elsworth United States
R.H. Roth United States
Edward D. Bird United States
Christine Konradi United States
Jeffrey N. Joyce
Citations per year, relative to Jeffrey N. Joyce Jeffrey N. Joyce (= 1×) peers Christine Konradi

Countries citing papers authored by Jeffrey N. Joyce

Since Specialization
Citations

This map shows the geographic impact of Jeffrey N. Joyce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey N. Joyce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey N. Joyce more than expected).

Fields of papers citing papers by Jeffrey N. Joyce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey N. Joyce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey N. Joyce. The network helps show where Jeffrey N. Joyce may publish in the future.

Co-authorship network of co-authors of Jeffrey N. Joyce

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey N. Joyce. A scholar is included among the top collaborators of Jeffrey N. Joyce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey N. Joyce. Jeffrey N. Joyce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kufahl, Peter R., et al.. (2009). c‐Fos expression associated with reinstatement of cocaine‐seeking behavior by response‐contingent conditioned cues. Synapse. 63(10). 823–835. 81 indexed citations
2.
Lockhart, Andrew, Janette Lamb, Tracy Osredkar, et al.. (2007). PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis. Brain. 130(10). 2607–2615. 232 indexed citations
3.
Joyce, Jeffrey N. & Mark J. Millan. (2006). Dopamine D3 receptor agonists for protection and repair in Parkinson's disease. Current Opinion in Pharmacology. 7(1). 100–105. 91 indexed citations
4.
Nakadate, Kazuhiko, Takahiro Noda, Shin‐ichi Sakakibara, et al.. (2006). Progressive dopaminergic neurodegeneration of substantia nigra in the zitter mutant rat. Acta Neuropathologica. 112(1). 64–73. 19 indexed citations
5.
Ueda, Shuichi, Shin‐ichi Sakakibara, Kazuhiko Nakadate, et al.. (2005). Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E. Neuroscience Letters. 380(3). 252–256. 20 indexed citations
8.
Hanger, Diane P., et al.. (2003). Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice. Pharmacology Biochemistry and Behavior. 76(3-4). 551–562. 10 indexed citations
9.
Joyce, Jeffrey N., H. Ryoo, John N. Caviness, et al.. (2002). Loss of response to levodopa in Parkinson’s disease and co-occurrence with dementia: role of D3 and not D2 receptors. Brain Research. 955(1-2). 138–152. 56 indexed citations
10.
Gurevich, Eugenia V., Jeffrey H. Kordower, & Jeffrey N. Joyce. (2000). Ontogeny of the dopamine D2 receptor mRNA expressing cells in the human hippocampal formation and temporal neocortex. Journal of Chemical Neuroanatomy. 20(3-4). 307–325. 8 indexed citations
11.
Joyce, Jeffrey N., et al.. (1999). D3Receptors and the Actions of Neuroleptics in the Ventral Striatopallidal System of Schizophrenics. Annals of the New York Academy of Sciences. 877(1). 595–613. 39 indexed citations
12.
Ryoo, H., et al.. (1998). Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease. Movement Disorders. 13(5). 788–797. 95 indexed citations
13.
Solbrig, Marylou V., George F. Koob, Jeffrey N. Joyce, & W. Ian Lipkin. (1996). A Neural Substrate of Hyperactivity in Borna Disease: Changes in Brain Dopamine Receptors. Virology. 222(2). 332–338. 41 indexed citations
14.
Piddington, R., Jeffrey N. Joyce, Padmaja Dhanasekaran, & L. Baker. (1996). Diabetes mellitus affects prostaglandin E2 levels in mouse embryos during neurulation. Diabetologia. 39(8). 915–920. 38 indexed citations
15.
Joyce, Jeffrey N., et al.. (1995). Alterations in hippocampal mossy fiber pathway in Schizophrenia and Alzheimer' s disease. Biological Psychiatry. 37(2). 122–126. 44 indexed citations
16.
Frohna, Paul, Bethany S. Neal‐Beliveau, & Jeffrey N. Joyce. (1995). Neonatal 6-hydroxydopamine lesions lead to opposing changes in the levels of dopamine receptors and their messenger RNAs. Neuroscience. 68(2). 505–518. 14 indexed citations
17.
Joyce, Jeffrey N., et al.. (1992). ABNORMALITIES OF SEROTONERGIC NEURAL TRANSMISSION IN PREFRONTAL CORTEX IN SCHIZOPHRENIA. Clinical Neuropharmacology. 15. 397A–398A. 2 indexed citations
18.
Murray, Angela M., H. Ryoo, & Jeffrey N. Joyce. (1992). Visualization of dopamine D3-like receptors in human brain with [125I]epidepride. European Journal of Pharmacology Molecular Pharmacology. 227(4). 443–445. 31 indexed citations
19.
Rao, Peter A., Perry B. Molinoff, & Jeffrey N. Joyce. (1991). Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Developmental Brain Research. 60(2). 161–177. 154 indexed citations
20.
Joyce, Jeffrey N., Nedra Lexow, Edward J. Bird, & Andrew Winokur. (1988). Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia. Synapse. 2(5). 546–557. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026